Sign up to save your podcasts
Or
Share How to Treat Diffuse Large B-Cell Lymphoma (DLBCL) in 2025
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
How to Treat Diffuse Large B-Cell Lymphoma (DLBCL) in 2025
Welcome to the Oncology Brothers podcast! In this episode, Drs. Rohit and Rahul Gosain dive deep into the world of diffuse large B-cell lymphoma (DLBCL), one of the most aggressive yet potentially curable lymphomas. We are joined by Dr. John Leonard, a renowned lymphoma expert from NYU Langone Cancer Center, who shares his insights on the latest data and evolving treatment landscape for DLBCL.
Episode Highlights:
• Understanding the initial workup for DLBCL, including the role of PET-CT and bone marrow biopsies.
• The use of RCHOP and the emerging Pola-R-CHP regimen in Stage 1 and Stage 2 settings.
• Discussion on the treatment options for Stage 3 and Stage 4 disease, including the impact of polatuzumab.
• Insights into managing relapsed/refractory disease and the role of CAR-T therapy.
• The potential shift towards outpatient CAR-T treatments and the nuances between different CAR-T options.
• Exploring bispecific antibodies and their applications in treatment sequencing.
YouTube: https://youtu.be/raGkPnUs9XM
Follow us on social media:
• X/Twitter: https://twitter.com/oncbrothers
• Instagram: https://www.instagram.com/oncbrothers
• Website: https://oncbrothers.com/
Join us as we unpack the complexities of DLBCL treatment and share valuable clinical pearls for community settings. Don't forget to subscribe for more episodes on challenging cases and the latest in oncology!
View all episodes
By Oncology Brothers
4.8
3939 ratings
Welcome to the Oncology Brothers podcast! In this episode, Drs. Rohit and Rahul Gosain dive deep into the world of diffuse large B-cell lymphoma (DLBCL), one of the most aggressive yet potentially curable lymphomas. We are joined by Dr. John Leonard, a renowned lymphoma expert from NYU Langone Cancer Center, who shares his insights on the latest data and evolving treatment landscape for DLBCL.
Episode Highlights:
• Understanding the initial workup for DLBCL, including the role of PET-CT and bone marrow biopsies.
• The use of RCHOP and the emerging Pola-R-CHP regimen in Stage 1 and Stage 2 settings.
• Discussion on the treatment options for Stage 3 and Stage 4 disease, including the impact of polatuzumab.
• Insights into managing relapsed/refractory disease and the role of CAR-T therapy.
• The potential shift towards outpatient CAR-T treatments and the nuances between different CAR-T options.
• Exploring bispecific antibodies and their applications in treatment sequencing.
YouTube: https://youtu.be/raGkPnUs9XM
Follow us on social media:
• X/Twitter: https://twitter.com/oncbrothers
• Instagram: https://www.instagram.com/oncbrothers
• Website: https://oncbrothers.com/
Join us as we unpack the complexities of DLBCL treatment and share valuable clinical pearls for community settings. Don't forget to subscribe for more episodes on challenging cases and the latest in oncology!
More shows like Oncology Brothers: Practice-Changing Cancer Discussions
View all
NEJM This Week
320 Listeners
Journal of Clinical Oncology (JCO) Podcast
42 Listeners
Research To Practice | Oncology Videos
111 Listeners
JAMA Clinical Reviews
501 Listeners
ASCO Daily News
60 Listeners
Core IM | Internal Medicine Podcast
1,110 Listeners
OncoPharm
182 Listeners
ASCO Guidelines
46 Listeners
OncLive® On Air
22 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
350 Listeners
Lung Cancer Considered
27 Listeners
The Passive Income MD Podcast
277 Listeners
Oncology Today with Dr Neil Love
60 Listeners
Two Onc Docs
181 Listeners
Blood Cancer Talks
48 Listeners